August 23, 2018
Antibody Discovery Market: Rise of Platform Providers

Owing to several beneficial features, such as high specificity, and a favorable safety profile, antibody (Ab) discovery based pharmacological interventions, with 79 molecules approved till date and over 200 molecules in the preclinical / discovery stages, presently represent the largest class of biologics. The antibody discovery market involves a long, arduous and cost intensive process.